APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endothelial Keratoplasty (EK)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Endothelial Keratoplasty (EK) Market Outlook and Growth Opportunities 2026

12 August 2026191 pages

Choose your research edition.

Industry ResearchEndothelial Keratoplasty (EK) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Endothelial Keratoplasty (EK) Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Endothelial Keratoplasty (EK) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endothelial Keratoplasty (EK) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Endothelial Keratoplasty (EK) Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global Endothelial Keratoplasty (EK) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Endothelial Keratoplasty (EK) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endothelial Keratoplasty (EK) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endothelial Keratoplasty (EK) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Endothelial Keratoplasty (EK) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Endothelial Keratoplasty (EK) market include Precise Bio, Altomed, CorneaGen, Mayo Clinic, Cellusion and LaserVision, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Endothelial Keratoplasty (EK) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endothelial Keratoplasty (EK) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endothelial Keratoplasty (EK) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Endothelial Keratoplasty (EK) market.

Endothelial Keratoplasty (EK) Segment by Company

Precise Bio

Altomed

CorneaGen

Mayo Clinic

Cellusion

LaserVision

Endothelial Keratoplasty (EK) Segment by Type

Descemet's Stripping Endothelial Keratoplasty (DSEK)

Descemet's Membrane Endothelial Keratosplaty (DMEK)

Endothelial Keratoplasty (EK) Segment by Application

Adults

Children

Endothelial Keratoplasty (EK) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Endothelial Keratoplasty (EK) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Endothelial Keratoplasty (EK) key companies, revenue, market share, and recent developments.

3. To split the Endothelial Keratoplasty (EK) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Endothelial Keratoplasty (EK) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Endothelial Keratoplasty (EK) significant trends, drivers, influence factors in global and regions.

6. To analyze Endothelial Keratoplasty (EK) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endothelial Keratoplasty (EK) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endothelial Keratoplasty (EK) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endothelial Keratoplasty (EK).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endothelial Keratoplasty (EK) industry.

Chapter 3: Detailed analysis of Endothelial Keratoplasty (EK) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Endothelial Keratoplasty (EK) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Endothelial Keratoplasty (EK) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Endothelial Keratoplasty (EK) Industry Trends Table 2. Endothelial Keratoplasty (EK) Industry Drivers Table 3. Endothelial Keratoplasty (EK) Industry Opportunities and Challenges Table 4. Endothelial Keratoplasty (EK) Industry Restraints Table 5. Global Endothelial Keratoplasty (EK) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Endothelial Keratoplasty (EK) Revenue Share by Company (2021-2026) Table 7. Global Endothelial Keratoplasty (EK) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Endothelial Keratoplasty (EK) Key Company Manufacturing Base & Headquarters Table 9. Global Endothelial Keratoplasty (EK) Company, Product Type & Application Table 10. Global Endothelial Keratoplasty (EK) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Endothelial Keratoplasty (EK) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Descemet's Stripping Endothelial Keratoplasty (DSEK) Table 15. Significant Companies of Descemet's Membrane Endothelial Keratosplaty (DMEK) Table 16. Global Endothelial Keratoplasty (EK) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Endothelial Keratoplasty (EK) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Endothelial Keratoplasty (EK) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Endothelial Keratoplasty (EK) Sales Value Share by Type (2021-2026) Table 20. Global Endothelial Keratoplasty (EK) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Adults Table 22. Significant Companies of Children Table 23. Global Endothelial Keratoplasty (EK) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Endothelial Keratoplasty (EK) Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Endothelial Keratoplasty (EK) Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Endothelial Keratoplasty (EK) Sales Value Share by Application (2021-2026) Table 27. Global Endothelial Keratoplasty (EK) Sales Value Share by Application (2027-2032) Table 28. Global Endothelial Keratoplasty (EK) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Endothelial Keratoplasty (EK) Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Endothelial Keratoplasty (EK) Sales Value Share by Region (2021-2026) Table 31. Global Endothelial Keratoplasty (EK) Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Endothelial Keratoplasty (EK) Sales Value Share by Region (2027-2032) Table 33. Global Endothelial Keratoplasty (EK) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Endothelial Keratoplasty (EK) Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Endothelial Keratoplasty (EK) Sales Value Market Share by Country (2021-2026) Table 36. Global Endothelial Keratoplasty (EK) Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Endothelial Keratoplasty (EK) Sales Value Market Share by Country (2027-2032) Table 38. Precise Bio Company Information Table 39. Precise Bio Business Overview Table 40. Precise Bio Endothelial Keratoplasty (EK) Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Precise Bio Endothelial Keratoplasty (EK) Product Portfolio Table 42. Precise Bio Recent Development Table 43. Altomed Company Information Table 44. Altomed Business Overview Table 45. Altomed Endothelial Keratoplasty (EK) Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Altomed Endothelial Keratoplasty (EK) Product Portfolio Table 47. Altomed Recent Development Table 48. CorneaGen Company Information Table 49. CorneaGen Business Overview Table 50. CorneaGen Endothelial Keratoplasty (EK) Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. CorneaGen Endothelial Keratoplasty (EK) Product Portfolio Table 52. CorneaGen Recent Development Table 53. Mayo Clinic Company Information Table 54. Mayo Clinic Business Overview Table 55. Mayo Clinic Endothelial Keratoplasty (EK) Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Mayo Clinic Endothelial Keratoplasty (EK) Product Portfolio Table 57. Mayo Clinic Recent Development Table 58. Cellusion Company Information Table 59. Cellusion Business Overview Table 60. Cellusion Endothelial Keratoplasty (EK) Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Cellusion Endothelial Keratoplasty (EK) Product Portfolio Table 62. Cellusion Recent Development Table 63. LaserVision Company Information Table 64. LaserVision Business Overview Table 65. LaserVision Endothelial Keratoplasty (EK) Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. LaserVision Endothelial Keratoplasty (EK) Product Portfolio Table 67. LaserVision Recent Development Table 68. Research Programs/Design for This Report Table 69. Authors List of This Report Table 70. Secondary Sources Table 71. Primary Sources List of Figures Figure 1. Endothelial Keratoplasty (EK) Product Image Figure 2. Global Endothelial Keratoplasty (EK) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endothelial Keratoplasty (EK) Market Size (2021-2032) & (US$ Million) Figure 4. Global Endothelial Keratoplasty (EK) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Descemet's Stripping Endothelial Keratoplasty (DSEK) Image Figure 8. Descemet's Membrane Endothelial Keratosplaty (DMEK) Image Figure 9. Global Endothelial Keratoplasty (EK) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Endothelial Keratoplasty (EK) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Endothelial Keratoplasty (EK) Sales Value Share by Type (2021-2032) Figure 12. Adults Image Figure 13. Children Image Figure 14. Global Endothelial Keratoplasty (EK) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Endothelial Keratoplasty (EK) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Endothelial Keratoplasty (EK) Sales Value Share by Application (2021-2032) Figure 17. Global Endothelial Keratoplasty (EK) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Endothelial Keratoplasty (EK) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Endothelial Keratoplasty (EK) Sales Value (2021-2032) & (US$ Million) Figure 20. North America Endothelial Keratoplasty (EK) Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Endothelial Keratoplasty (EK) Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Endothelial Keratoplasty (EK) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Endothelial Keratoplasty (EK) Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Endothelial Keratoplasty (EK) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Endothelial Keratoplasty (EK) Sales Value (2021-2032) & (US$ Million) Figure 26. South America Endothelial Keratoplasty (EK) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Endothelial Keratoplasty (EK) Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Endothelial Keratoplasty (EK) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Descemet's Stripping Endothelial Keratoplasty (DSEK)
  • Descemet's Membrane Endothelial Keratosplaty (DMEK)
Applications
  • Adults
  • Children
Companies covered
  • Precise Bio
  • Altomed
  • CorneaGen
  • Mayo Clinic
  • Cellusion
  • LaserVision

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Endothelial Keratoplasty (EK) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Endothelial Keratoplasty (EK) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Endothelial Keratoplasty (EK) Market Dynamics
  1. 2.1 Endothelial Keratoplasty (EK) Industry Trends
  2. 2.2 Endothelial Keratoplasty (EK) Industry Drivers
  3. 2.3 Endothelial Keratoplasty (EK) Industry Opportunities and Challenges
  4. 2.4 Endothelial Keratoplasty (EK) Industry Restraints
3 Endothelial Keratoplasty (EK) Market by Company
  1. 3.1 Global Endothelial Keratoplasty (EK) Company Revenue Ranking in 2025
  2. 3.2 Global Endothelial Keratoplasty (EK) Revenue by Company (2021-2026)
  3. 3.3 Global Endothelial Keratoplasty (EK) Company Ranking (2024-2026)
  4. 3.4 Global Endothelial Keratoplasty (EK) Company Manufacturing Base and Headquarters
  5. 3.5 Global Endothelial Keratoplasty (EK) Company Product Type and Application
  6. 3.6 Global Endothelial Keratoplasty (EK) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Endothelial Keratoplasty (EK) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Endothelial Keratoplasty (EK) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Endothelial Keratoplasty (EK) Market by Type
  1. 4.1 Endothelial Keratoplasty (EK) Type Introduction
  2. 4.1.1 Descemet's Stripping Endothelial Keratoplasty (DSEK)
  3. 4.1.2 Descemet's Membrane Endothelial Keratosplaty (DMEK)
  4. 4.2 Global Endothelial Keratoplasty (EK) Sales Value by Type
  5. 4.2.1 Global Endothelial Keratoplasty (EK) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Endothelial Keratoplasty (EK) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Endothelial Keratoplasty (EK) Sales Value Share by Type (2021-2032)
5 Endothelial Keratoplasty (EK) Market by Application
  1. 5.1 Endothelial Keratoplasty (EK) Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Endothelial Keratoplasty (EK) Sales Value by Application
  5. 5.2.1 Global Endothelial Keratoplasty (EK) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Endothelial Keratoplasty (EK) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Endothelial Keratoplasty (EK) Sales Value Share by Application (2021-2032)
6 Endothelial Keratoplasty (EK) Regional Value Analysis
  1. 6.1 Global Endothelial Keratoplasty (EK) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endothelial Keratoplasty (EK) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Endothelial Keratoplasty (EK) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Endothelial Keratoplasty (EK) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Endothelial Keratoplasty (EK) Sales Value (2021-2032)
  7. 6.3.2 North America Endothelial Keratoplasty (EK) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Endothelial Keratoplasty (EK) Sales Value (2021-2032)
  10. 6.4.2 Europe Endothelial Keratoplasty (EK) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Endothelial Keratoplasty (EK) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Endothelial Keratoplasty (EK) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Endothelial Keratoplasty (EK) Sales Value (2021-2032)
  16. 6.6.2 South America Endothelial Keratoplasty (EK) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Endothelial Keratoplasty (EK) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Endothelial Keratoplasty (EK) Sales Value Share by Country, 2025 VS 2032
7 Endothelial Keratoplasty (EK) Country-level Value Analysis
  1. 7.1 Global Endothelial Keratoplasty (EK) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Endothelial Keratoplasty (EK) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Endothelial Keratoplasty (EK) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Endothelial Keratoplasty (EK) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Endothelial Keratoplasty (EK) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Endothelial Keratoplasty (EK) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Endothelial Keratoplasty (EK) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Precise Bio
  2. 8.1.1 Precise Bio Company Information
  3. 8.1.2 Precise Bio Business Overview
  4. 8.1.3 Precise Bio Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Precise Bio Endothelial Keratoplasty (EK) Product Portfolio
  6. 8.1.5 Precise Bio Recent Developments
  7. 8.2 Altomed
  8. 8.2.1 Altomed Company Information
  9. 8.2.2 Altomed Business Overview
  10. 8.2.3 Altomed Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Altomed Endothelial Keratoplasty (EK) Product Portfolio
  12. 8.2.5 Altomed Recent Developments
  13. 8.3 CorneaGen
  14. 8.3.1 CorneaGen Company Information
  15. 8.3.2 CorneaGen Business Overview
  16. 8.3.3 CorneaGen Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CorneaGen Endothelial Keratoplasty (EK) Product Portfolio
  18. 8.3.5 CorneaGen Recent Developments
  19. 8.4 Mayo Clinic
  20. 8.4.1 Mayo Clinic Company Information
  21. 8.4.2 Mayo Clinic Business Overview
  22. 8.4.3 Mayo Clinic Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mayo Clinic Endothelial Keratoplasty (EK) Product Portfolio
  24. 8.4.5 Mayo Clinic Recent Developments
  25. 8.5 Cellusion
  26. 8.5.1 Cellusion Company Information
  27. 8.5.2 Cellusion Business Overview
  28. 8.5.3 Cellusion Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cellusion Endothelial Keratoplasty (EK) Product Portfolio
  30. 8.5.5 Cellusion Recent Developments
  31. 8.6 LaserVision
  32. 8.6.1 LaserVision Company Information
  33. 8.6.2 LaserVision Business Overview
  34. 8.6.3 LaserVision Endothelial Keratoplasty (EK) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LaserVision Endothelial Keratoplasty (EK) Product Portfolio
  36. 8.6.5 LaserVision Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst